AMD3100 synergizes with G-CSF to mobilize repopulating stem cells in Fanconi anemia knockout mice

Experimental Hematology

Volumn 36, Issue 9, 2008, Pages 1084-1090

  Pulliam, Anna C ^a,b   Hobson, M Joe ^a,b   Ciccone, Samantha L ^a,b   Li, Yan ^a,b   Chen, Shi ^a,b   Srour, Edward F ^a   Yang, Feng Chun ^a,b   Broxmeyer, Hal E ^a,b   Clapp, D Wade ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; PLERIXAFOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; C57BL 6 MOUSE; CELL POPULATION; CONTROLLED STUDY; DISEASE MODEL; DRUG POTENTIATION; FANCONI ANEMIA; GRAFT RECIPIENT; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION; STEM CELL MOBILIZATION; WILD TYPE;

ANIMALS; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP A PROTEIN; FANCONI ANEMIA COMPLEMENTATION GROUP C PROTEIN; GRAFT SURVIVAL; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HETEROCYCLIC COMPOUNDS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RADIATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

MURINAE; MUS;

EID: 49349095512     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2008.03.016     Document Type: Article

References (43)

1. Kutler D.I., Singh B., Satagopan J., et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 101 (2003) 1249-1256
2. Gluckman E., and Rocha V. History of the clinical use of umbilical cord blood hematopoietic cells. Cytotherapy 7 (2005) 219-227
3. Gluckman E., Auerbach A.D., Horowitz M.M., et al. Bone marrow transplantation for Fanconi anemia. Blood 86 (1995) 2856-2862
4. Thompson L.H. Unraveling the Fanconi anemia-DNA repair connection. Nat Genet 37 (2005) 921-922
5. Meetei A.R., Sechi S., Wallisch M., et al. A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome. Mol Cell Biol 23 (2003) 3417-3426
6. Levitus M., Rooimans M.A., Steltenpool J., et al. Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes. Blood 103 (2004) 2498-2503
7. Meetei A.R., Medhurst A.L., Ling C., et al. A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat Genet 37 (2005) 958-963
8. Levitus M., Waisfisz Q., Godthelp B.C., et al. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. Nat Genet 37 (2005) 934-935
9. Levran O., Attwooll C., Henry R.T., et al. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Nat Genet 37 (2005) 931-933
10. Joenje H., and Patel K.J. The emerging genetic and molecular basis of Fanconi anaemia. Nat Rev Genet 2 (2001) 446-459
11. Taniguchi T., and Dandrea A.D. Molecular pathogenesis of fanconi anemia. Int J Hematol 75 (2002) 123-128
12. Positional cloning of the Fanconi anaemia group A gene. The Fanconi anaemia/breast cancer consortium. Nat Genet 14 (1996) 324-328
13. de Winter J.P., Leveille F., van Berkel C.G., et al. Isolation of a cDNA representing the Fanconi anemia complementation group E gene. Am J Hum Genet 67 (2000) 1306-1308
14. de Winter J.P., van der Weel L., de Groot J., et al. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum Mol Genet 9 (2000) 2665-2674
15. de Winter J.P., Waisfisz Q., Rooimans M.A., et al. The Fanconi anaemia group G gene FANCG is identical with XRCC9. Nat Genet 20 (1998) 281-283
16. Hejna J.A., Timmers C.D., Reifsteck C., et al. Localization of the Fanconi anemia complementation group D gene to a 200-kb region on chromosome 3p25.3. Am J Hum Genet 66 (2000) 1540-1551
17. Joenje H., Levitus M., Waisfisz Q., et al. Complementation analysis in Fanconi anemia: assignment of the reference FA-H patient to group A. Am J Hum Genet 67 (2000) 759-762
18. Joenje H., Oostra A.B., Wijker M., et al. Evidence for at least eight Fanconi anemia genes. Am J Hum Genet 61 (1997) 940-944
19. Lo Ten Foe J.R., Rooimans M.A., Bosnoyan-Collins L., et al. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nat Genet 14 (1996) 320-323
20. Meetei A.R., de Winter J.P., Medhurst A.L., et al. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat Genet 35 (2003) 165-170
21. Pronk J.C., Gibson R.A., Savoia A., et al. Localisation of the Fanconi anaemia complementation group A gene to chromosome 16q24.3. Nat Genet 11 (1995) 338-340
22. Rahman N., Seal S., Thompson D., et al. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 39 (2007) 165-167
23. Reid S., Schindler D., Hanenberg H., et al. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet 39 (2007) 162-164
24. Strathdee C.A., Duncan A.M., and Buchwald M. Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9. Nat Genet 1 (1992) 196-198
25. Strathdee C.A., Gavish H., Shannon W.R., and Buchwald M. Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature 358 (1992) 434
26. Timmers C., Taniguchi T., Hejna J., et al. Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol Cell 7 (2001) 241-248
27. Wevrick R., Clarke C.A., and Buchwald M. Cloning and analysis of the murine Fanconi anemia group C cDNA. Hum Mol Genet 2 (1993) 655-662
28. Whitney M., Thayer M., Reifsteck C., et al. Microcell mediated chromosome transfer maps the Fanconi anaemia group D gene to chromosome 3p. Nat Genet 11 (1995) 341-343
29. Haneline L.S., Gobbett T.A., Ramani R., et al. Loss of FancC function results in decreased hematopoietic stem cell repopulating ability. Blood 94 (1999) 1-8
30. Li X., Le Beau M.M., Ciccone S., et al. Ex vivo culture of Fancc -/- stem/ progenitor cells predisposes cells to undergo apoptosis and surviving stem/progenitor cells display cytogenetic abnormalities and an increased risk of malignancy. Blood 105 (2005) 3465-3471
31. Mohle R., and Kanz L. Hematopoietic growth factors for hematopoietic stem cell mobilization and expansion. Semin Hematol 44 (2007) 193-202
32. Croop J.M., Cooper R., Fernandez C., et al. Mobilization and collection of peripheral blood CD34+ cells from patients with Fanconi anemia. Blood 98 (2001) 2917-2921
33. Lapidot T., and Kollet O. The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2m(null) mice. Leukemia 16 (2002) 1992-2003
34. Broxmeyer H.E., Orschell C.M., Clapp D.W., et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 201 (2005) 1307-1318
35. Flomenberg N., Devine S.M., Dipersio J.F., et al. The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone. Blood 106 (2005) 1867-1874
36. Haneline L.S., Li X., Ciccone S.L., et al. Retroviral-mediated expression of recombinant Fancc enhances the repopulating ability of Fancc-/- hematopoietic stem cells and decreases the risk of clonal evolution. Blood 101 (2003) 1299-1307
37. Si Y., Ciccone S., Yang F.C., et al. Continuous in vivo infusion of interferon-gamma (IFN-gamma) enhances engraftment of syngeneic wild-type cells in Fanca-/- and Fancg-/- mice. Blood 108 (2006) 4283-4287
38. Harrison D.E. Competitive repopulation: a new assay for long-term stem cell functional capacity. Blood 55 (1980) 77-81
39. Carreau M., Gan O.I., Liu L., Doedens M., Dick J.E., and Buchwald M. Hematopoietic compartment of Fanconi anemia group C null mice contains fewer lineage-negative CD34+ primitive hematopoietic cells and shows reduced reconstruction ability. Exp Hematol 27 (1999) 1667-1674
40. Robinson S.N., Seina S.M., Gohr J.C., and Sharp J.G. Hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor and erythropoietin in the absence of matrix metalloproteinase-9. Stem Cells Dev 14 (2005) 317-328
41. Robinson S.N., Pisarev V.M., Chavez J.M., Singh R.K., and Talmadge J.E. Use of matrix metalloproteinase (MMP)-9 knockout mice demonstrates that MMP-9 activity is not absolutely required for G-CSF or Flt-3 ligand-induced hematopoietic progenitor cell mobilization or engraftment. Stem Cells 21 (2003) 417-427
42. Levesque J.P., Liu F., Simmons P.J., et al. Characterization of hematopoietic progenitor mobilization in protease-deficient mice. Blood 104 (2004) 65-72
43. Pelus L.M., Bian H., King A.G., and Fukuda S. Neutrophil-derived MMP-9 mediates synergistic mobilization of hematopoietic stem and progenitor cells by the combination of G-CSF and the chemokines GRObeta/CXCL2 and GRObetaT/CXCL2delta4. Blood 103 (2004) 110-119